AU4707900A - Methods for controlling intraocular pressure - Google Patents

Methods for controlling intraocular pressure

Info

Publication number
AU4707900A
AU4707900A AU47079/00A AU4707900A AU4707900A AU 4707900 A AU4707900 A AU 4707900A AU 47079/00 A AU47079/00 A AU 47079/00A AU 4707900 A AU4707900 A AU 4707900A AU 4707900 A AU4707900 A AU 4707900A
Authority
AU
Australia
Prior art keywords
methods
intraocular pressure
controlling intraocular
controlling
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47079/00A
Inventor
Mortimer M. Civan
Anthony D. Macknight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU4707900A publication Critical patent/AU4707900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU47079/00A 1999-05-07 2000-05-08 Methods for controlling intraocular pressure Abandoned AU4707900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13318099P 1999-05-07 1999-05-07
US60133180 1999-05-07
PCT/US2000/012551 WO2000067756A1 (en) 1999-05-07 2000-05-08 Methods for controlling intraocular pressure

Publications (1)

Publication Number Publication Date
AU4707900A true AU4707900A (en) 2000-11-21

Family

ID=22457378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47079/00A Abandoned AU4707900A (en) 1999-05-07 2000-05-08 Methods for controlling intraocular pressure

Country Status (2)

Country Link
AU (1) AU4707900A (en)
WO (1) WO2000067756A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060013814A1 (en) * 2000-08-29 2006-01-19 Davies Collison Cave Methods for preventing pressure-induced apoptotic neural-cell death
WO2005079781A1 (en) * 2004-02-25 2005-09-01 La Trobe University Therapeutic and/or prophylactic method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215991A (en) * 1990-01-26 1993-06-01 Allergan, Inc. Combination of selective alpha-adrenergic agonists and Na+ /H+ ex
US5932572A (en) * 1992-02-21 1999-08-03 Alcon Laboratories, Inc. Topical anti-glaucoma compositions
US5545626A (en) * 1994-01-19 1996-08-13 The Trustees Of Columbia University In The City Of New York Method of treating glaucoma with oligonucleotides
DE19633966A1 (en) * 1996-08-22 1998-02-26 Hoechst Ag Phenyl-substituted alkenylcarboxylic acid guanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them

Also Published As

Publication number Publication date
WO2000067756A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
AU3219000A (en) Controlling production
AU6756300A (en) Method for inducing hypothermia
AU3211900A (en) Flow controller
AU4307301A (en) Phacoemulsification apparatus
AU6036000A (en) Method for flow control
AU1854901A (en) Novel method
AU2002333819A1 (en) Methods for controlling screenouts
AU4369400A (en) Phase controlled phacoemulsification
AU2042301A (en) 1-aminoalkyl-1H-indoles for treating glaucoma
AU7533498A (en) Method for adjusting supply pressure
AU7453900A (en) 4-oxybenzopyran derivative
AU2002320861A1 (en) Method for controlling fermentation
AU7053500A (en) Chymotrypsin-free trypsin
AU2001240557A1 (en) Implant for cranioplastics
AU2001267899A1 (en) Pharmaceutical compositions for controlling intraocular pressure
AU4707900A (en) Methods for controlling intraocular pressure
AU6712100A (en) Control valve unit
AU6984800A (en) Valve
AU6773800A (en) Method for controlling fungi using phenylhydrazine derivatives
AU2273500A (en) Hand controller
AU7923000A (en) Emulsifiers
AU5552200A (en) Method
AU1647101A (en) Device for setting gas pressure levels
AU3986300A (en) A method for controlling nematodes
AU6065300A (en) Methods for controlling fungal pathogens

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase